AML: Patienten profitieren von FLT3-Inhibition
Crossref DOI link: https://doi.org/10.1007/s15015-018-4257-7
Published Online: 2018-10-01
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wedekind, Silke
Text and Data Mining valid from 2018-10-01
Article History
First Online: 1 October 2018